Riskpilot← Back to searchSign inGet full accessEmireb AB
ABActiveOrg 5590104039Mickelsbergsvägen 236General medical practice activities · NACE 8621Est. 20151 employees
Revenue 2024
SEK 701K
-35% vs 2023
EBITDA margin
55.5%
+265% vs 2023
Equity ratio
59.3%
Financial strength
Net profit 2024
SEK 273K
+180% vs 2023
| Revenue | SEK 701K | -35% |
| EBITDA | SEK 389K | +265% |
| Net profit | SEK 273K | +180% |
| Total assets | SEK 2,7M | -8% |
| Equity | SEK 1,6M | +20% |
| Employees | 1 | — |
Legal name
Emireb AB
Org number
5590104039
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
14 april 2015
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet är att bedriva konsultverksamhet, personaluthyrning och verksamhetsutveckling inom hälso- och sjukvårdsområdet. Översättning och tolkning. Handel med livsmedel och inredningsartiklar samt äga och förvalta såväl fast som lös egendom, aktier och andra värdepapper samt därmed förenlig verksamhet.
Address
Mickelsbergsvägen 236
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 761 | 1 817 | 1 650 | 1 079 | 701 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 697 | 384 | 332 | −236 | 389 |
| Depreciation & amort. | −39 | −49 | −60 | −61 | −61 |
| EBIT | 658 | 335 | 272 | −297 | 328 |
| Net financials | −39 | −20 | −21 | −49 | −45 |
| Profit before tax | 620 | 315 | 251 | −345 | 283 |
| Tax | −135 | −71 | −56 | 2 | −10 |
| Net profit | 485 | 244 | 195 | −343 | 273 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 3 024 | 3 156 | 3 155 | 2 957 | 2 723 |
| Equity | 1 496 | 1 490 | 1 685 | 1 342 | 1 614 |
| Long-term debt | 1 020 | 968 | 915 | 878 | 818 |
| Short-term debt | 508 | 699 | 556 | 737 | 291 |
| Total debt | 1 528 | 1 667 | 1 471 | 1 615 | 1 109 |
EBITDA margin
55.5%
This company
15.8%
Market median
+251% vs market
20202024
Equity ratio
59.3%
This company
38.2%
Market median
+55% vs market
20202024
Return on equity
16.9%
This company
18.4%
Market median
+8% vs market
20202024
Net profit margin
38.9%
This company
8.1%
Market median
+380% vs market
20202024
Asset turnover
0.26×
This company
1.12×
Market median
-77% vs market
20202024
Debt / equity
0.69×
This company
0.62×
Market median
+11% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Emireb AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Pierre Robert Risberg | Deputy Board Member | 0 companies |
| Thuc Doan Risberg | Board of Directors | 0 companies |